Oct. 25 2024
Source Page: Sodium zirconium cyclosilicate for treating hyperkalaemia (partial review of TA599) [ID6439]Found: Health Technology Evaluation: Scoping Equality impact assessment for the Health Technology Evaluation
Jan. 23 2008
Source Page: Single Equality Scheme 2007–2010. 120 p.Found: Single Equality Scheme 2007–2010. 120 p.
Oct. 01 2024
Source Page: Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer [ID6177]Found: Health Technology Evaluation : Scoping Equality impact assessment for the Health Technology Evaluation
Oct. 22 2024
Source Page: Datopotamab deruxtecan for treating advanced non-small-cell lung cancer after platinum-based chemotherapy [ID6241]Found: Health Technology Evaluation : Scoping Equality impact assessment for the Health Technology Evaluation
Oct. 29 2024
Source Page: Zanubrutinib for treating relapsed or refractory mantle cell lymphoma after 1 or more treatments ID6392Found: Health Technology Evaluation: Scoping Equality impact assessment for the Health Technology Evaluation
Oct. 08 2024
Source Page: Fruquintinib for previously treated metastatic colorectal cancer ID6274Found: previously treated metastatic colorectal cancer Issue date: October 2024 NATIONAL INSTITUTE FOR HEALTH AND
Sep. 18 2024
Source Page: Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuriaFound: , and, if so, how ?
Sep. 11 2024
Source Page: Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and overFound: Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and over
Sep. 06 2024
Source Page: Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer ID6339Found: Health Technology Evaluation : Scoping Equality impact assessment for the Health Technology Evaluation
Oct. 30 2024
Source Page: Equality and Human Rights Mainstreaming Strategy: Consultation - Easy ReadFound: Equality and Human Rights Mainstreaming Strategy: Consultation - Easy Read